Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Pediatric Drugs
Erschienen in: Pediatric Drugs 1/2008

01.01.2008 | Therapy In Practice

Management of Chronic Daily Headache in Children and Adolescents

verfasst von: Dr Kenneth J. Mack, Jack Gladstein

Erschienen in: Pediatric Drugs | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Chronic daily headache (CDH) occurs in 1–2% of children and adolescents. It can evolve from either episodic tension-type headache or episodic migraine, or can appear with no previous headache history. As with other primary headache disorders, treatment is based on the level of disability. There are children and adolescents who cope well, but there are others who are markedly disabled by their chronic headaches. As in adults, children and adolescents with CDH are at risk for medication overuse.
CDH is a diagnosis of exclusion, based on a thorough history, normal physical examination, and negative neuroimaging findings. Along with the chronic headaches, children with this condition may have co-morbid sleep problems, autonomic dysfunction, anxiety, and/or depression. Principles of treatment include identifying migrainous components, stopping medication overuse, stressing normalcy, using rational pharmacotherapy, and addressing co-morbid conditions. Successful outcomes often involve identifying an appropriate headache preventative, reintegration into school, and family participation in resetting realistic expectations.
Literatur
1.
International Headache Society. International classification of headache disorders (ICHD-II). Cephalalgia 2004; 24(Suppl. 1) 23–136
2.
Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006; 66: 193–7PubMedCrossRef
3.
Kavuk I, Yavuz A, Cetindere U, et al. Epidemiology of chronic daily headache. Eur J Med Res 2003; 8: 236–40PubMed
4.
Gladstein J, Holden EW, Peralta L, et al. Diagnoses and symptom patterns in children presenting to a Pediatric headache clinic. Headache 1993; 33: 497–500PubMedCrossRef
5.
Hershey AD, Powers SW, Bentti AL, et al. Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology 2001; 56: 1032–7PubMedCrossRef
6.
Silberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34: 1–7CrossRef
7.
Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47: 871–5PubMedCrossRef
8.
Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol 2004; 1: 122–5CrossRef
9.
Gladstein J, Holden EW. Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 1996; 36: 349–51PubMedCrossRef
10.
Koenig MA, Gladstein J, McCarter RJ, et al. Pediatric Committee of the American Headache Society. Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache 2002 Jun; 42(6): 491–500PubMedCrossRef
11.
Howard L, Wessely S, Leese M, et al. Are investigations anxiolytic or anxiogenic? A randomized controlled trial of neuroimaging to provide reassurance in chronic daily headace. J Neurol Neurosurg Psychiatry 2005; 76(11): 1558–64PubMedCrossRef
12.
Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994; 44: 1353–4
13.
Schwedt TJ, Guo Y, Rothner AD. “Benign” imaging abnormalities in children and adolescents with headache. Headache 2006; 46: 387–98PubMedCrossRef
14.
Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001; 57: 2034–9PubMedCrossRef
15.
Mathew NT, Kurman R, Perez F. Drug induced refractory headache: clinical features and management. Headache 1990; 30: 634–8PubMedCrossRef
16.
Maizels M, Burchette R. Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and co morbidity. Headache 2004; 44: 983–93PubMedCrossRef
17.
Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc 2007; 82(3): 308–13PubMed
18.
Silberstein SD, Liu D. Drug overuse and rebound headache. Curr Pain Headache Rep 2002; 6: 240–7PubMedCrossRef
19.
Relja G, Granato A, Bratina A, et al. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 2006 May; 26(5): 589–95PubMedCrossRef
20.
Raskin NH. Repetitive intravenous ergotamine therapy for the treatment of intractable migraine. Neurology 1986; 36: 995–7PubMedCrossRef
21.
Mathew NT, Kailasam J, Meadors L, et al. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000; 40: 720–3PubMedCrossRef
22.
Krymchantowski AV, Barbosa JS. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. Arq Neuropsiquiatr 2001; 59: 708–11PubMedCrossRef
23.
Lewis D, Ashwal S, Hershey A, et al. American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004; 63: 2215–24PubMedCrossRef
24.
Linde K, Rossnagel K. Propanolol for migraine prophylaxis. Cochrane Database Syst Rev 2004; 2: CD003225
25.
26.
Borzy JC, Koch TK, Schimschock JR. Effectiveness of topimarate in the treatment of Pediatric chronic daily headache. Pediatr Neurol 2005; 33(5): 314–6PubMedCrossRef
27.
Comer SD, Haney M, Fischman MW, et al. Cyproheptadine produced modest increases in total caloric intake by humans. Physiol Behav 1997; 62: 831–9PubMedCrossRef
28.
Colombo B, Annovazzi PO, Comi G. Therapy of primary headaches: the role of antidepressants. Neurol Sci 2004; 25Suppl. 3: S171–5PubMedCrossRef
29.
Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004; 3: CD003226
30.
Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997; 20: 427–51PubMedCrossRef
31.
Gherpelli JL, Esposito SB. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents. Arq Neuropsiquiatr 2005; 63: 559–63PubMedCrossRef
32.
Adelman LC, Adelman JU, VonSeggern R, et al. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000; 40: 572–80PubMedCrossRef
33.
Bianchi A, Salomone S, Caraci F, et al. Role of magnesium, coenzymeQ10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm 2004; 69: 297–312PubMedCrossRef
34.
Dodick DW, Mauskop A, Elkind AH, et al. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005; 45: 315–24PubMedCrossRef
35.
Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback 2002; 27: 163–81PubMedCrossRef
36.
Hershey AD, Powers SW, Bentti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40: 539–49PubMedCrossRef
37.
Galli F, Patron L, Russo PM, et al. Chronic daily headache in childhood and adolescence: clinical aspects and a 4-year follow-up. Cephalalgia 2004; 24: 850–8PubMedCrossRef
Metadaten
Titel
Management of Chronic Daily Headache in Children and Adolescents
verfasst von
Dr Kenneth J. Mack
Jack Gladstein
Publikationsdatum
01.01.2008
Verlag
Springer International Publishing
Erschienen in
Pediatric Drugs / Ausgabe 1/2008
Print ISSN: 1174-5878
Elektronische ISSN: 1179-2019
DOI
https://doi.org/10.2165/00148581-200810010-00003

Weitere Artikel der Ausgabe 1/2008

Pediatric Drugs 1/2008 Zur Ausgabe

Review Article

Managing Crohn Disease in Children and Adolescents

Review Article

Clinical Uses of Dexmedetomidine in Pediatric Patients

Review Article

Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

Therapy In Practice

Dysmenorrhea in Adolescents

Therapy In Practice

Corticosteroid-Resistant Nephrotic Syndrome with Focal and Segmental Glomerulosclerosis

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise